Company profile for Liminal BioSciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Liminal BioSciences is a global biotechnology company that specialises in discovering, developing and commercializing novel small molecule compounds for respiratory, liver and renal diseases. We focus specifically on developing solutions for rare and orphan diseases. Liminal BioSciences operates on an integrated basis from our three talent hubs in Laval, Quebec, Canada, Cambridge, UK and Rockville, Maryland, USA. Our common sh...
Liminal BioSciences is a global biotechnology company that specialises in discovering, developing and commercializing novel small molecule compounds for respiratory, liver and renal diseases. We focus specifically on developing solutions for rare and orphan diseases. Liminal BioSciences operates on an integrated basis from our three talent hubs in Laval, Quebec, Canada, Cambridge, UK and Rockville, Maryland, USA. Our common shares are listed for trading on the Nasdaq Global Market and Toronto Stock Exchange (Symbol: LMNL).

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
440 Armand-Frappier Blvd., Suite 300 Laval, Québec H7V 4B4
Telephone
Telephone
+1.450.781.0115
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/liminal-takes-buyout-top-shareholder-peach-price

Max Bayer FIERCE BIOTECH
12 Jul 2023

https://www.fiercebiotech.com/biotech/annexon-liminal-shrink-pipelines-prioritize-potential-homerun-candidates

Max Bayer FIERCE BIOTECH
09 Jan 2023

https://www.prnewswire.com/news-releases/liminal-biosciences-to-present-at-hc-wainwright-24th-annual-global-investment-conference-301613447.html

PRNEWSWIRE
29 Aug 2022

https://biopharmaapac.com/news/48/1931/liminal-biosciences-announces-termination-of-legacy-cdmo-contract.html

BIOPHARMA APAC
27 Aug 2022

https://www.prnewswire.com/news-releases/liminal-biosciences-announces-first-subject-dosed-in-phase-1a-single-ascending-dose-clinical-trial-of-fezagepras-301552529.html

PRNEWSWIRE
23 May 2022

https://www.globenewswire.com/news-release/2022/01/27/2374469/0/en/Ocugen-Inc-Signs-Letter-of-Intent-to-Acquire-Vaccine-Manufacturing-R-D-Hub-in-Ontario-Canada.html

GLOBENEWSWIRE
27 Jan 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty